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Abstract 
Background: Hepatitis B virus (HBV) can be prevented and controlled through 
vaccination.  However, vaccination among high-risks adults in the U.S. is still low (50%).  
This poses serious threats for HBV transmission between infected individuals and high-
risk individuals.  
Objective: The specific aims of this research were to: (a) explore the prevalence of 
hepatitis B vaccination uptake from 2011-2014 (b) to examine intrapersonal, 
interpersonal, and organizational level factors associated with receiving hepatitis B 
vaccination among high-risk adults.  
Methods: Data were analyzed from the National Health and Nutrition Examination 
Survey (NHANES) from 2011-2014 to: (1) asses the prevalence of hepatitis B 
vaccination and (2) examine the interpersonal, intrapersonal, and organizational level 
factors associated with receiving the hepatitis B vaccination among U.S. adults. 
Results: Of the 5,379 participants, 464 (weighted 8.6%) were considered high-risk adults 
and 4,915 (weighted 91.4%) were considered non-high-risk adults. Overall, vaccination 
uptake for high-risk adults was (50.5%) and (53.7%) for non-high risk adults.  There 
were statistically significant differences between high-risk and non-high-risk based on 
race, education, and previous reception of Hep A vaccination.  
Discussion: This study illustrated that: (a) hepatitis B vaccination uptake among high-
risk adults is improving, but is still less than optimal (b) individual, social, and 
environmental factors play a role in receipt of vaccination among high-risk adults.  As a 
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result, these individual, social, and environmental factors could serve as a driving force to 
improve vaccination among high-risk adults.  
 
Conclusion:  Efforts to increase access and use of educational programs may 
significantly combat certain social and environmental factors that have been linked to low 
vaccination rates among high-risk populations. Additionally, the implementation of 
stricter ACIP vaccination recommendations should be considered by Federal associations 
as a means of increasing vaccination among the general population.   
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Introduction: 
Hepatitis B is defined as chronic or acute inflammation of the liver caused by the 
hepatitis B virus (HBV).  Hepatitis B infection is generally spread through percutaneous 
or mucosal exposure to infected blood or other bodily fluids (Center for Disease Control 
and Prevention, 2006). Due to the likelihood of transmitting HBV to others, individuals 
with chronic hepatitis B are considered primary reservoirs for continuous transmission.  
Although the development of chronic infection is most often seen in infants and young 
children, rates of new infections and acute hepatitis are highest among adults (Center for 
Disease Control and Prevention, 2006). Recent findings indicate that: a) 20% of all new 
HBV infections in the U.S. are among MSMs. b) 25.8% of new cases are among those 
that indicated use of some form of injection drug(s) c) 10% of people with HIV are co-
infected with HBV (HIV and Viral Hepatitis, 2014, March), (Statistics and Surveillance, 
2016, May 19). The increased probability of contracting Hepatitis B places injection drug 
users, men who have sex with men, and HIV positive patients at high-risk.   
Since 1982, the hepatitis B vaccine has been recommended for high risk adults, 
such as those with a history of sexually transmitted disease (STDs), men who have sex 
with men, HIV infected persons, high-risk heterosexuals (e.g.,> multiple sex partners), 
and injection drug users. (IDUs) (Center for Disease Control and Prevention, 1982). 
Despite standing suggestions and access to universal vaccinations, an estimated 240 
million people suffer from chronic hepatitis B globally (Statistics and Surveillance, 2016, 
May 19).  Americans make up approximately 850,000- 2.2 million of the total cases 
worldwide (Roberts et al., 2015).  
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Past attempts to combat these numbers, include the 1991 endorsement of a 
national strategy to eliminate HBV by the Advisory Committee on Immunization 
Practices (ACIP) and other medical organizations (Center for Disease Control and 
Prevention, 1991).  This strategy called for: 1) screening all pregnant women and 
immunizing infants and infected mothers to prevent perinatal transmission 2) universal 
vaccination of infants to prevent infections during childhood and at later ages 3) 
provision of catch up vaccinations for children and adolescents not previously vaccinated 
and 4) vaccination of high risk adults and adolescents. Furthermore, in December 2006, 
ACIP updated its recommendations to include the provision of hepatitis B vaccination in 
prevention service settings where there is active visitation from unvaccinated, high risk 
adults.  These settings include: testing and treatment facilities for Human 
Immunodeficiency Virus and other Sexually Transmitted Diseases, drug abuse treatment 
and prevention settings, health care settings geared toward Injection Drug Users and Men 
who have Sex with Men, correctional facilities, chronic hemodialysis facilities and end 
stage renal programs, and institutions and nonresidential day care facilities for 
developmentally disabled persons (Center for Disease Control and Prevention, 2006).   
There has been significant progress in vaccination rates and coverage among 
children (92%) and adolescents (67%). However, only 50% of high-risk adults in the 
United States (U.S.) have been vaccinated against HBV infection (Lu, Byrd, Murphy, & 
Weinbaum, 2011). Such low vaccination rates pose serious threats for the transmission of 
hepatitis B virus infection to others.  
The specific aims of this research were to: (a) explore the prevalence of hepatitis 
B vaccination uptake from 2011-2014 (b) to examine intrapersonal, interpersonal, and 
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organizational level factors associated with receiving hepatitis B vaccination among high-
risk adults.  
Methods 
Data were analyzed from the National Health and Nutrition Examination Survey 
(NHANES) from 2011- 2014 to: (1) assess the prevalence of hepatitis B vaccination 
uptake and (2) examine the intrapersonal, interpersonal, and organizational level factors 
that may be associated with receiving the hepatitis B vaccination among U.S. adults. A 
high-risk adult was defined as any adult reporting at least one of the following: a sexually 
transmitted infection in the past 12 month (e.g., herpes, chlamydia, gonorrhea, or genital 
warts), sex with another man is male, infection with HIV, or past or current injection drug 
use. All other adults were classified as non- high-risk.  A literature review was performed 
to collect information regarding the correlation between high-risk individuals and 
vaccination rates and the factors that influence the two.  Publications dates were limited 
to the year(s) 2011-2016.  
Results 
Table 1 shows the sample characteristics of adults, aged 18-49 years for the 2011 to 
2014-time period. A total of 5,379 adults aged 18-49 years were interviewed. Of the 
5,379 participants, 464 (weighted 8.6%) were considered high risk adults and 4,915 
(weighted 91.4%) were considered non-high-risk adults. The majority of the sample was 
non-Hispanic White (58.7%), female sex (50.6%), between the ages 21-40 (61.2%), 
married (49.0%), had greater than a high school education (64.7%), lived at or above the 
poverty line (78.5%), and had health insurance (74.3%). 
 
Table 1 Sample Characteristics of Adult, Aged 18-49 Years, NHANES 2011-2014 
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 High-Risk vs Non-High-Risk 
 Sample N [Weighted col % (95%CI)] 
Factors Among All-Adults High-Risk (n=584) Non-High-Risk (n=5909) 
    
Overall 5379 [ 100.0 (. -. ) ] 464 [ 100.0 (.-.) ] 4915 [ 100.0 (. -. ) ] 
    
HB3Dose    
complete 3 doses 2924 [ 53.4 ( 51.4 -55.4 ) ] 250 [ 50.5 (45.1 -55.9) ] 2674 [53.7 ( 51.6 -55.8 ) ] 
no doses 2455 [ 46.6 ( 44.6 -48.6 ) ] 214 [ 49.5 (44.1 -54.9) ] 2241 [46.3 (44.2 -48.4 ) ] 
    
Gender    
Male 3163 [ 49.4 ( 48.1 -50.7 ) ] 265 [ 47.1 ( 40.8 -53.5 ) ] 2898 [ 49.7 ( 48.2 -51.1 ) ] 
Female 3330 [ 50.6 ( 49.3 -51.9 ) ] 319 [ 52.9 ( 46.5 -59.2 ) ] 3011 [ 50.3 ( 48.9 -51.8 ) ] 
    
Age Grp    
18-20 875 [ 10.1 ( 8.7 -11.7 ) ] 45 [ 5.5 ( 3.5 -8.4 ) ] 830 [ 10.6 ( 9.2 -12.2 ) ] 
21-25 1025 [ 16.5 ( 14.5 -18.6 ) ] 93 [ 15.8 ( 11.4 -21.4 ) ] 932 [ 16.6 ( 14.6 -18.7 ) ] 
26-30 918 [ 14.8 ( 13.1 -16.6 ) ] 86 [ 14.6 ( 11.4 -18.5 ) ] 832 [ 14.8 ( 13.0 -16.7 ) ] 
31-40 1955 [ 29.9 ( 28.3 -31.6 ) ] 170 [ 28.2 ( 23.6 -33.3 ) ] 1785 [ 30.1 ( 28.3 -32.0 ) ] 
41-49 1720 [ 28.7 ( 26.3 -31.3 ) ] 190 [ 35.9 ( 30.3 -41.8 ) ] 1530 [ 27.9 ( 25.4 -30.5 ) ] 
    
Race    
NH-White 2335 [ 58.7 ( 53.0 -64.2 ) ] 280 [ 69.9 ( 63.3 -75.8 ) ] 2055 [ 57.4 ( 51.6 -63.0 ) ] 
NH-Black 1455 [ 12.6 ( 9.8 -16.1 ) ] 154 [ 13.1 ( 9.1 -18.5 ) ] 1301 [ 12.6 ( 9.9 -16.0 ) ] 
Mexican American 901 [ 11.7 ( 9.0 -15.2 ) ] 50 [ 6.5 ( 4.4 -9.6 ) ] 851 [ 12.4 ( 9.4 -16.1 ) ] 
Others 1802 [ 16.9 ( 14.7 -19.2 ) ] 100 [ 10.5 ( 8.0 -13.7 ) ] 1702 [ 17.6 ( 15.4 -20.1 ) ] 
    
Edu    
<=High school 2280 [ 35.3 ( 31.7 -39.0 ) ] 196 [ 34.8 ( 28.6 -41.6 ) ] 2084 [ 35.3 ( 31.8 -39.0 ) ] 
>High school 3561 [ 64.7 ( 61.0 -68.3 ) ] 352 [ 65.2 ( 58.4 -71.4 ) ] 3209 [ 64.7 ( 61.0 -68.2 ) ] 
    
Marital    
Married 2687 [ 49.0 ( 45.7 -52.3 ) ] 186 [ 38.7 ( 31.8 -46.1 ) ] 2501 [ 50.3 ( 47.2 -53.3 ) ] 
widowed/divorced/sep
arated 
616 [ 10.5 ( 9.4 -11.7 ) ] 70 [ 13.1 ( 10.2 -16.6 ) ] 546 [ 10.2 ( 8.9 -11.6 ) ] 
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 High-Risk vs Non-High-Risk 
 Sample N [Weighted col % (95%CI)] 
Factors Among All-Adults High-Risk (n=584) Non-High-Risk (n=5909) 
Never married 2540 [ 40.5 ( 36.6 -44.5 ) ] 292 [ 48.2 ( 41.1 -55.4 ) ] 2248 [ 39.5 ( 35.8 -43.4 ) ] 
    
Poverty    
<=1 1736 [ 21.6 ( 18.1 -25.4 ) ] 164 [ 19.9 ( 15.2 -25.5 ) ] 1572 [ 21.8 ( 18.3 -25.6 ) ] 
1-4.99 3302 [ 57.4 ( 53.9 -60.8 ) ] 306 [ 58.3 ( 50.9 -65.4 ) ] 2996 [ 57.3 ( 54.0 -60.5 ) ] 
>=5 952 [ 21.1 ( 17.8 -24.7 ) ] 86 [ 21.8 ( 16.2 -28.7 ) ] 866 [ 21.0 ( 17.7 -24.6 ) ] 
    
INSURANCE    
Yes 4549 [ 74.3 ( 71.8 -76.7 ) ] 421 [ 77.8 ( 71.7 -83.0 ) ] 4128 [ 73.9 ( 71.3 -76.3 ) ] 
No 1935 [ 25.7 ( 23.3 -28.2 ) ] 161 [ 22.2 ( 17.0 -28.3 ) ] 1774 [ 26.1 ( 23.7 -28.7 ) ] 
    
CarePlace    
clinic or health center 1196 [ 21.3 ( 18.6 -24.3 ) ] 98 [ 20.7 ( 14.0 -29.6 ) ] 1098 [ 21.4 ( 18.9 -24.1 ) ] 
doctor office or HMO 3285 [ 71.0 ( 67.8 -74.0 ) ] 324 [ 71.8 ( 62.9 -79.3 ) ] 2961 [ 70.9 ( 67.8 -73.8 ) ] 
hospital emergency 
room 
288 [ 4.7 ( 3.8 -5.8 ) ] 31 [ 4.6 ( 2.8 -7.5 ) ] 257 [ 4.7 ( 3.8 -5.8 ) ] 
hospital outpatient 
department 
68 [ 1.1 ( 0.8 -1.5 ) ] 6 [ 0.6 ( 0.2 -1.5 ) ] 62 [ 1.2 ( 0.8 -1.6 ) ] 
some other place 100 [ 1.9 ( 1.4 -2.7 ) ] 12 [ 2.2 ( 1.3 -3.8 ) ] 88 [ 1.9 ( 1.4 -2.7 ) ] 
    
CareTime    
None 1426 [ 21.3 ( 19.7 -23.0 ) ] 81 [ 12.8 ( 10.4 -15.7 ) ] 1345 [ 22.3 ( 20.5 -24.2 ) ] 
one time 1520 [ 23.6 ( 22.2 -25.2 ) ] 117 [ 19.9 ( 16.2 -24.3 ) ] 1403 [ 24.1 ( 22.4 -25.8 ) ] 
2-3 time 1778 [ 29.9 ( 28.6 -31.4 ) ] 159 [ 31.5 ( 26.8 -36.5 ) ] 1619 [ 29.8 ( 28.3 -31.3 ) ] 
4-9 time 890 [ 15.4 ( 14.4 -16.5 ) ] 110 [ 21.0 ( 17.0 -25.6 ) ] 780 [ 14.8 ( 13.6 -16.0 ) ] 
>=10 time 554 [ 9.7 ( 8.7 -10.8 ) ] 71 [ 14.8 ( 11.5 -18.9 ) ] 483 [ 9.1 ( 8.1 -10.2 ) ] 
    
HEPADose    
1-2 doses 2610 [ 44.9 ( 43.0 -46.8 ) ] 229 [ 45.5 ( 39.7 -51.3 ) ] 2381 [ 44.8 ( 42.6 -47.0 ) ] 
no doses 2840 [ 55.1 ( 53.2 -57.0 ) ] 257 [ 54.5 ( 48.7 -60.3 ) ] 2583 [ 55.2 ( 53.0 -57.4 ) ] 
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Table 2 shows the factors associated with hepatitis B vaccination vaccine uptake greater 
than three doses for ages 18-49 years for the 2011-2014 time period.  Overall, vaccination 
uptake for high-risk adults was (50.5%) and (53.7%) for non-high risk adults. There was 
statistical significance differences seen between high-risk and non-high risk by race, 
education, and previous reception of hepatitis A vaccination.   There was no statistical 
significance differences seen between high-risk and non-risk by race, age group, gender, 
marital status, socioeconomic status, insurance, care place or care time.  
 
 
 
 
TABLE 2 – Factors Associated with Hepatitis B Vaccination Uptake by High-Risk Status and 
Individual, Intrapersonal, and Organizational Characteristics, NHANES, 20011-2014 
 High-Risk Non-High-Risk  
 High-Risk with Sample N [Weighted % (95%CI)] Non-High-Risk with Sample N [Weighted % (95%CI)]  
Factors N(col%) Uptake>=3 dose n(row%) N(col%) Uptake>=3 dose n(row%) 
P-
value 
      
Overall 464 [ 100.0 ( . -. ) ] 250 [ 50.5 ( 45.1 -55.9 ) ] 4915 [ 100.0 ( . -. ) ] 2674 [ 53.7 ( 51.6 -55.8 ) ] 0.268 
      
Gender      
Male 205 [ 46.4 ( 39.6 -53.3 ) ] 102 [ 43.6 ( 35.5 -52.1 ) ] 2413 [ 49.5 ( 47.8 -51.3 ) ] 1210 [ 48.8 ( 46.1 -51.4 ) ] 0.225 
Female 259 [ 53.6 ( 46.7 -60.4 ) ] 148 [ 56.5 ( 49.1 -63.6 ) ] 2502 [ 50.5 ( 48.7 -52.2 ) ] 1464 [ 58.6 ( 55.7 -61.4 ) ] 0.550 
      
Age Grp      
18-20 35 [ 5.8 ( 3.5 -9.5 ) ] 27 [ 84.4 ( 60.2 -95.0 ) ] 692 [ 10.8 ( 9.3 -12.6 ) ] 543 [ 78.3 ( 72.9 -82.8 ) ] 0.488 
21-25 76 [ 17.0 ( 12.6 -22.6 ) ] 53 [ 67.6 ( 53.7 -79.0 ) ] 766 [ 16.1 ( 14.2 -18.3 ) ] 549 [ 72.7 ( 67.9 -77.0 ) ] 0.464 
26-30 63 [ 14.0 ( 10.6 -18.3 ) ] 36 [ 55.0 ( 39.5 -69.7 ) ] 684 [ 14.6 ( 12.8 -16.7 ) ] 412 [ 64.2 ( 59.6 -68.6 ) ] 0.254 
31-40 136 [ 28.7 ( 23.8 -34.3 ) ] 68 [ 45.7 ( 37.5 -54.2 ) ] 1464 [ 29.7 ( 27.9 -31.6 ) ] 685 [ 46.5 ( 43.5 -49.5 ) ] 0.862 
41-49 154 [ 34.5 ( 29.0 -40.4 ) ] 66 [ 38.5 ( 27.3 -51.1 ) ] 1309 [ 28.7 ( 26.0 -31.5 ) ] 485 [ 35.8 ( 32.2 -39.6 ) ] 0.646 
      
Race      
NH-White 220 [ 70.2 ( 63.1 -76.4 ) ] 107 [ 47.3 ( 40.6 -54.0 ) ] 1737 [ 58.3 ( 52.5 -63.9 ) ] 941 [ 54.4 ( 51.7 -57.1 ) ] 0.046
3* 
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 High-Risk Non-High-Risk  
 High-Risk with Sample N [Weighted % (95%CI)] Non-High-Risk with Sample N [Weighted % (95%CI)]  
Factors N(col%) Uptake>=3 dose n(row%) N(col%) Uptake>=3 dose n(row%) 
P-
value 
NH-Black 129 [ 14.0 ( 9.6 -19.9 ) ] 76 [ 57.4 ( 46.1 -68.0 ) ] 1130 [ 13.1 ( 10.2 -16.6 ) ] 649 [ 56.7 ( 52.4 -60.8 ) ] 0.897 
Mexican 
American 
37 [ 5.9 ( 3.9 -8.7 ) ] 17 [ 46.7 ( 32.1 -61.8 ) ] 665 [ 11.6 ( 8.7 -15.2 ) ] 292 [ 43.2 ( 37.4 -49.2 ) ] 0.688 
Others 78 [ 10.0 ( 7.5 -13.3 ) ] 50 [ 65.8 ( 55.2 -75.0 ) ] 1383 [ 17.1 ( 15.0 -19.4 ) ] 792 [ 56.1 ( 52.6 -59.6 ) ] 0.083
4 
      
Edu      
<=High 
school 
150 [ 34.6 ( 28.3 -41.5 ) ] 76 [ 50.8 ( 41.0 -60.6 ) ] 1715 [ 34.8 ( 31.0 -38.8 ) ] 703 [ 41.1 ( 38.0 -44.4 ) ] 0.042
3* 
>High 
school 
286 [ 65.4 ( 58.5 -71.7 ) ] 153 [ 48.3 ( 41.3 -55.5 ) ] 2685 [ 65.2 ( 61.2 -69.0 ) ] 1567 [ 57.7 ( 55.0 -60.4 ) ] 0.011
3* 
      
Marital      
Married 143 [ 37.1 ( 30.2 -44.6 ) ] 70 [ 45.5 ( 33.9 -57.6 ) ] 2057 [ 49.9 ( 46.6 -53.1 ) ] 981 [ 48.1 ( 44.7 -51.5 ) ] 0.648 
widowed/di
vorced/separate
d 
59 [ 13.7 ( 10.4 -17.8 ) ] 28 [ 37.3 ( 22.6 -54.7 ) ] 462 [ 10.4 ( 9.1 -11.9 ) ] 216 [ 43.3 ( 36.7 -50.1 ) ] 0.505 
Never 
married 
234 [ 49.2 ( 42.1 -56.3 ) ] 131 [ 55.3 ( 46.0 -64.3 ) ] 1884 [ 39.7 ( 35.9 -43.7 ) ] 1074 [ 59.1 ( 54.8 -63.2 ) ] 0.422 
      
Poverty      
<=1 132 [ 20.3 ( 15.5 -26.1 ) ] 68 [ 51.1 ( 38.6 -63.4 ) ] 1303 [ 21.7 ( 18.2 -25.6 ) ] 754 [ 58.4 ( 53.8 -62.9 ) ] 0.216 
1-4.99 238 [ 57.8 ( 50.5 -64.8 ) ] 133 [ 51.1 ( 43.5 -58.8 ) ] 2492 [ 57.2 ( 53.8 -60.6 ) ] 1327 [ 51.6 ( 49.0 -54.2 ) ] 0.906 
>=5 71 [ 21.9 ( 16.5 -28.4 ) ] 35 [ 47.9 ( 34.3 -61.9 ) ] 725 [ 21.1 ( 17.7 -24.9 ) ] 397 [ 55.5 ( 51.4 -59.6 ) ] 0.254 
      
INSURANCE      
Yes 333 [ 76.8 ( 70.1 -82.4 ) ] 186 [ 52.4 ( 45.0 -59.7 ) ] 3449 [ 74.1 ( 71.4 -76.6 ) ] 2002 [ 56.7 ( 54.4 -59.0 ) ] 0.265 
No 131 [ 23.2 ( 17.6 -29.9 ) ] 64 [ 44.2 ( 34.3 -54.7 ) ] 1463 [ 25.9 ( 23.4 -28.6 ) ] 671 [ 45.0 ( 41.1 -49.0 ) ] 0.875 
      
CarePlace      
clinic or 
health center 
77 [ 20.6 ( 12.9 -31.2 ) ] 49 [ 54.4 ( 43.2 -65.1 ) ] 915 [ 21.1 ( 18.3 -24.2 ) ] 481 [ 51.6 ( 47.0 -56.2 ) ] 0.631 
doctor office 
or HMO 
264 [ 72.1 ( 61.4 -80.7 ) ] 145 [ 51.5 ( 42.0 -60.8 ) ] 2500 [ 71.2 ( 67.7 -74.5 ) ] 1454 [ 56.4 ( 53.9 -58.9 ) ] 0.276 
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 High-Risk Non-High-Risk  
 High-Risk with Sample N [Weighted % (95%CI)] Non-High-Risk with Sample N [Weighted % (95%CI)]  
Factors N(col%) Uptake>=3 dose n(row%) N(col%) Uptake>=3 dose n(row%) 
P-
value 
hospital 
emergency 
room 
26 [ 5.1 ( 2.9 -8.8 ) ] 12 [ 39.1 ( 22.8 -58.1 ) ] 217 [ 4.7 ( 3.6 -6.0 ) ] 109 [ 49.6 ( 43.2 -55.9 ) ] 0.316 
hospital 
outpatient 
department 
5 [ 0.7 ( 0.2 -1.8 ) ] 4 [ 62.0 ( 13.8 -94.3 ) ] 51 [ 1.1 ( 0.7 -1.6 ) ] 30 [ 63.9 ( 49.6 -76.1 ) ] 0.943 
some other 
place 
7 [ 1.6 ( 0.8 -3.1 ) ] 4 [ 48.5 ( 17.4 -80.8 ) ] 74 [ 1.9 ( 1.4 -2.8 ) ] 43 [ 55.4 ( 42.8 -67.4 ) ] 0.736 
      
CareTime      
None 67 [ 14.2 ( 11.4 -17.6 ) ] 25 [ 36.6 ( 25.1 -49.8 ) ] 1098 [ 21.9 ( 20.2 -23.7 ) ] 519 [ 46.7 ( 42.7 -50.8 ) ] 0.140
0 
one time 92 [ 20.8 ( 15.9 -26.8 ) ] 55 [ 53.6 ( 40.2 -66.5 ) ] 1162 [ 23.9 ( 22.1 -25.8 ) ] 643 [ 53.7 ( 49.8 -57.7 ) ] 0.981 
2-3 time 122 [ 29.6 ( 24.7 -35.0 ) ] 69 [ 52.0 ( 42.2 -61.6 ) ] 1342 [ 29.7 ( 28.0 -31.5 ) ] 749 [ 54.2 ( 50.9 -57.3 ) ] 0.674 
4-9 time 88 [ 20.3 ( 16.1 -25.2 ) ] 52 [ 61.3 ( 48.0 -73.0 ) ] 651 [ 15.0 ( 13.6 -16.6 ) ] 374 [ 58.6 ( 53.2 -63.7 ) ] 0.710 
>=10 time 60 [ 15.1 ( 11.6 -19.4 ) ] 32 [ 46.2 ( 31.5 -61.5 ) ] 413 [ 9.4 ( 8.4 -10.5 ) ] 246 [ 59.0 ( 52.8 -65.0 ) ] 0.114
7 
      
HEPADose      
1-2 doses 200 [ 44.5 ( 38.5 -50.7 ) ] 172 [ 80.7 ( 72.9 -86.7 ) ] 2181 [ 44.1 ( 41.7 -46.5 ) ] 1960 [ 89.2 ( 87.3 -90.7 ) ] 0.011
6* 
no doses 232 [ 55.5 ( 49.3 -61.5 ) ] 64 [ 29.0 ( 22.7 -36.3 ) ] 2433 [ 55.9 ( 53.5 -58.3 ) ] 516 [ 23.8 ( 21.3 -26.4 ) ] 0.165
7 
 
 
Discussion 
Hepatitis B can be prevented through vaccination.  Among high risk adults the prevalence 
of hepatitis B vaccination had a slight increase from 47.0% in 2007-2010 to 51.0% in 
2011-2014.    This study illustrated that hepatitis B vaccination uptake among high-risk 
adults is getting better but is still less than optimal. Although hepatitis B vaccination 
uptake was relatively low, this study illustrated that individual, social, and environmental 
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factors play a role in receipt of vaccination among high-risk adults.  As a result, these 
individual, social, and environmental factors could serve as driving forces to improve 
vaccination coverage among high-risk adults. Thus strategies to promote education about 
hepatitis B vaccination among high risk adults could assist with increasing vaccination 
rates. 
Conclusion 
Programs established by public health officials to be implemented in local health 
departments, educational environments (i.e. high-schools or universities), and specific 
areas where high-risk populations are prominent should be strongly considered. Efforts to 
increase access and use of educational programs may significantly combat certain social 
and environmental factors that have been linked to low vaccination rates among high-risk 
populations.  In addition to educational efforts, updated ACIP recommendation strategies 
that call for stricter vaccination practices among the general population may also lead to 
an overall increase in the rate of Hepatitis B vaccination uptake. 
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Abstract: 
Background:  Hepatitis B is a completely preventable disease. However, the rise in 
highly educated, middle class, anti-vaccine communities has increased the fear of 
government officials that infectious diseases that could be potentially eradicated will 
reappear or rise in prevalence. 
Objective: The purpose of this study was to determine the degree of the influence of 
education on: 
1. hepatitis B knowledge and awareness regarding the general understanding of the 
infection, hepatitis B preventability, and hepatitis B transmission.  
2. vaccine use as a preventative measure for hepatitis B and other life threatening, 
preventable diseases.  
3. beliefs regarding parental decisions to vaccinate children 
Methods: Data were analyzed to determine the existence of a correlational relationship 
between education and (a) knowledge and awareness regarding the general understanding 
of the infection, hepatitis B preventability, and hepatitis B transmission (b) vaccine use as 
a preventative measure for hepatitis B and other life threatening, preventable diseases (c) 
beliefs regarding parental decisions to vaccinate 
Results:  The total sample consisted of sixteen freshmen, (13.01%), twenty-six 
sophomores (21.14%), thirty juniors (24.39%), thirty-three seniors (26.83%), and 
eighteen graduate students (14.63%).  There were statistically significant differences 
between familiarity with hepatitis B based on classification and some evidence that 
science majors may be more knowledgeable of hepatitis B.  
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Discussion: An increase in the number of U.S. parents and educated individual 
expressing opposition to vaccinations against Hepatitis B and other infectious diseases 
poses a significant threat of the re-introduction of infectious diseases among non-
vaccinated populations. 
Conclusion:   A lack of knowledge and awareness of hepatitis B infection and 
transmission and vaccine use among highly educated students indicates the need for the 
implementation of specific educational programs at the University of MS directed 
towards; (a) increasing knowledge and awareness of preventable diseases, such as 
hepatitis B, (b) minimizing social stigmas associated with these topics, and (c)  
encouraging and increasing the use of strong educational backgrounds, specifically in 
science related subjects, to motivate others to consider the risk side of  infectious diseases 
even when the symptoms are not visible.   
		 22	
 
Introduction: 
 
 In 2014, there were an estimated 19,200 new hepatitis B virus infections in the 
United States. In the United States, an estimated 850,000-2.2 million persons have 
chronic hepatitis B. Globally, chronic hepatitis B affects approximately 240 million 
people and contributes to an estimated 786,000 deaths each year (Centers for Disease 
Control and Prevention, 2016). Most people who are diagnosed with chronic hepatitis B 
were infected at birth or during early childhood. It is reported that approximately 90% of 
infected infants will develop a chronic infection (Centers for Disease Control and 
Prevention, 2016).  Although the risk goes down as a child gets older approximately 
25%–50% of children infected between the ages of 1 and 5 years will develop chronic 
hepatitis. (Centers for Disease Control and Prevention, 2016). Children with chronic 
hepatitis B may display no physical signs or symptoms of chronic infection making it 
very difficult to detect. These children are at increased risk for developing serious liver 
problems like cirrhosis or liver cancer. (Children’s Hospital of Philadelphia, 2013).  
 Since 1982, the hepatitis B vaccine has been recommended for high risk adults, 
such as those with a history of sexually transmitted disease (STDs), men who have sex 
with men (MSMs), HIV infected persons, high-risk heterosexuals (e.g.,>multiple sex 
partners), and injection drug users (IDUs) (Centers for Disease Control and Prevention, 
1982).   In 1991 the Advisory Committee on Immunization Practices (ACIP) endorsed a 
national strategy to eliminate HBV (Centers for Disease for Control and Prevention, 
1991). This strategy called for: 1) screening all pregnant women and immunizing infants 
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and infected mothers to prevent perinatal transmission 2) universal vaccinations for 
children and adolescents not previously vaccinated and 3) vaccination of high risk adults 
and adolescents. In 1995, ACIP recommended the routine vaccination of adolescents 11-
12 years who had not been vaccinated previously and in 1999, ACIP recommended that 
all unvaccinated children aged <19 years be vaccinated (Centers for Disease Control and 
Prevention, 2002).  Furthermore, in December 2006, ACIP updated its recommendations 
to include the prevision of hepatitis B vaccination in prevention service settings where 
there is active visitation from unvaccinated, high risk adults. These settings include: 
testing and treatment facilities for Human Immunodeficiency Virus and other Sexually 
Transmitted Diseases, drug abuse treatment and prevention settings, health care setting 
geared toward injection drug users and men who have sex with men, correctional 
facilities, chronic hemodialysis facilities and end stage renal programs, and institutions 
and nonresidential day care facilities for developmentally disabled person (Centers for 
Disease Control and Prevention, 2006).  
  Nonetheless, the ACIP vaccination strategies for children and adolescents have 
been implemented successfully in the United States, and hepatitis B is now considered 
part of the routine childhood vaccination schedule (Centers for Disease Control and 
Prevention, 2002).  During the years 1993-2000, the national coverage rates for hepatitis 
B vaccine among children 19-35 months increased from 16% to 90% and the coverage 
rate for U.S. adolescents aged 13-15 years increased from near zero to 67%. (Centers for 
Disease Control and Prevention, 2002).  The rate of this success of modern ACIP 
recommendations is often associated with: (a) the enactment of the national program, 
Vaccines for Children, in 1994, which purchases ACIP- recommended vaccines for 
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eligible children aged <19 years, (b) the enactment of laws mandating hepatitis B 
vaccination for children entering elementary school and childcare centers in forty-four 
states and requiring vaccinations for adolescents in middle school in thirty-four states. 
(Centers for Disease Control and Prevention, 2002) 
 In July of 2016, The Centers for Disease Control and Prevention’s National 
Center for Immunization and Respiratory Diseases updated its original statement that the 
best protection against hepatitis B is by getting the hepatitis B vaccine (Centers for 
Disease Control and Prevention, 2014). Doctors recommended that all parents vaccinate 
their child/children to: (a) protect their child/children against hepatitis B (b) protect other 
people from the disease because children with hepatitis B usually don’t have symptoms, 
but they often pass the disease to others without anyone knowing they were infected. (c) 
prevent their child from liver disease and cancer from hepatitis B. and (d) keep their child 
from missing school or childcare (Centers for Disease Control and Prevention, 2014).  
According to the Centers for Disease Control and Prevention, the hepatitis B vaccine is 
very safe and effective at preventing hepatitis B; like any medicine, the vaccine, can have 
side effects. However, no serious side effects are known to be caused by the hepatitis B 
vaccine (Center for Disease Control and Prevention, 2014).  To further address parental 
concerns regarding the vaccination of their infant(s), the National Center for 
Immunization released the following statement, 
  “It’s hard to imagine putting your newborn through the pain of a shot. But a 
little stick early in life is an important first step to protecting your baby against a deadly 
disease.  All babies should get the first shot of hepatitis B vaccine before they leave the 
hospital.  This shot acts as a safety net, reducing the risk of getting the disease from 
moms or family members who may not know they are infected with hepatitis B. When a 
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mom has hepatitis B, there’s an additional medicine that can help protect the baby 
against hepatitis B, called the hepatitis B immune globulin (HBIG). HBIG gives a baby’s 
body a “boost” or extra help to fight the virus as soon as he/she is born. This shot works 
best when the baby gets it within the first 12 hours of his/her life.  The baby will also need 
to complete the full hepatitis vaccination series for best protection”.  (Centers for 
Disease Control and Prevention, 2014) 
 
  Despite standing ACIP and CDC recommendations, laws, and recent statistical 
findings that support the notion of hepatitis B vaccination among infants, an increasing 
number of U.S. parents are expressing opposition to current hepatitis B vaccine 
regulations. Parents across the U.S. have contacted the National Vaccine Information 
Center (NVIC) to report their opposition to hepatitis B regulations being enacted by their 
state health departments officials. (National Vaccine Information Center, 1998).   
Previously reported reasons for parental opposition include: (a) Hepatitis is B not highly 
contagious (b) Hepatitis B is not a killer disease for most (c) Hepatitis B is low in the 
U.S. (d) Federal health officials give state health officials money to force hepatitis B 
Vaccination (e) The pharmaceutical industry also funds forced hepatitis B 
vaccination (f) Pharmacist now vaccinate (g) Families are now being penalized for 
refusing hepatitis B vaccine (h) Hepatitis B vaccine is licensed by the FDA without 
adequate proof of long term safety (i) Hepatitis B efficacy has been questioned (j) 
The Institute of Medicine report reveals lack of adequate scientific studies (k) 
Medical literature cites immune system/brain damage and (l) Vaccine injuries have 
been reported at the National Vaccine Information Center. (National Vaccine 
Information Center, 1998). As a result of parental opposition, an increasing number of 
schools and employers are pressured from government health officials to require 
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individuals to provide proof of hepatitis B vaccination before being allowed to enter work 
places or schools.  This rise in opposition by educated parents may lead to a rise in U.S. 
parents who choose to use religious or health related exemptions that permit attendance 
in public/private schools systems without few or all recommended vaccines. 
 The Centers for Disease Control and Prevention has discovered certain 
communities with a large population of parents who either do not vaccinate their children 
or pick and choose which vaccines to permit and how they are scheduled (Public 
Broadcasting Service, 2014). The 2015 Frontline Public Broadcasting Service (PBS) 
documentary, The Vaccine War, highlights a cluster of Americans in Ashland Oregon, a 
community of financially advantaged, educated individuals, who strongly oppose the 
vaccination of their young children.  Since 2010, parents from the Ashland community 
have gradually increased their dismissal of vaccine use. Because of the existence of 
vaccine exemptions, some 28% of Ashland’s kids are allowed to attend public schools 
lacking some or all of their required vaccinations (Public Broadcasting Service, 2014). As 
a result, it now has one of the lowest vaccination rates in the country. The rise in highly 
educated, middle class anti-vaccine communities like Ashland has increased fears of 
government officials that diseases like hepatitis B and many others that could be 
potentially eradicated will reappear (Public Broadcasting Service, 2014).  
 
According to previous findings by the Centers for Disease Control and Preventions 
Division of Viral Hepatitis, individual, social and environmental factors may play a role 
in the uptake of hepatitis B vaccinations and hepatitis B vaccine opposition (Centers for 
Disease Control and Prevention, 2016). In addition, these findings also indicate that 
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strategies to promote education about hepatitis B vaccination could assist with reducing 
opposition and decreasing the influence of negative stigmas regarding hepatitis B 
vaccination.  
  The purpose of this study was to determine the degree of the influence of 
education on: 
4. hepatitis B knowledge and awareness regarding the general understanding of the 
infection, hepatitis B preventability, and hepatitis B transmission.  
5. vaccine use as a preventative measure for hepatitis B and other life threatening, 
preventable diseases.  
6. beliefs regarding parental decisions to vaccinate children 
Methods: 
Data were analyzed to determine the existence of a correlational relationship between 
education and (a) knowledge and awareness regarding the general understanding of the 
infection, hepatitis B preventability, and hepatitis B transmission (b) vaccine use as a 
preventative measure for hepatitis B and other life threatening, preventable diseases (c) 
beliefs regarding parental decisions to vaccinate. All subjects were eighteen or older and 
currently enrolled as part-time or full-time students at one of six University of 
Mississippi campuses.  Recruitment for sample participants involved the use of social 
media (i.e. posting flyers on specific class social media pages), email distribution, in class 
announcements to students, posting flyers on club and organization newsfeeds, and a 
randomized sampling collection by the University of Mississippi’s Institutional Review 
Board.  
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Tables 1 and 2 were classified using a 2-way classification table and tables 1, 2, 3, 5, and 
6 were evaluated using a 95% conference interval. Sample proportions for classification 
tables 2, 3, 5, and 6 were assessed using a sample tests for equality of proportions with 
continuity correction and table 1 was assessed using a sample test for equality of 
proportions without continuity correction.  A 10% significance level was used during the 
analysis of table 1 to account for any possible limitations associated with population size.  
Lastly, table 4 was assessed using a Fisher’s exact test for count data.  
Results: 
Knowledge and Awareness of Hepatitis B and Vaccine Uptake Among University of 
Mississippi Students 
 
Graph A 
Q: Are you familiar with Hepatitis B? 
 
 
 
 
 
 
  
The graph above illustrated the overall familiarity of hepatitis B among University of 
Mississippi students. Seventy-nine respondents (64.75%) reported they were familiar 
with Hepatitis B and forty-three respondents (35.25%) reported they were not familiar 
with hepatitis B. 
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Graph B 
Q: If familiar, which of the following best aligns with your definition of Hepatitis B? 
 
 
 
 
 
 
 
 
 The graph above illustrates students’ responses to the definition of hepatitis B. 
Eighty-one students (84.38%) chose the correct response, hepatitis B is a viral infection 
that attacks liver, twelve students (12.50%) responded hepatitis B is a viral infection that 
attacks the kidneys, three students (3.13%) reported hepatitis B is a viral infection that 
attacks the spleen.  
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Graph C 
 
Q: Have you previously received any vaccination against the Hepatitis B Virus? 
	
	
	
 The graph above illustrates the number of individual who are aware of their 
current hepatitis B vaccination status.  Fifty-seven students (47.1%) reported they had 
previously received the hepatitis B vaccine, twenty students (16.5%) reported they had 
not previously received the hepatitis B vaccine, and forty-four (36.4%) reported they 
were unaware of their hepatitis B vaccination status.  
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Graph D 
Q: Based on your knowledge, is Hepatitis B a preventable disease? 
 
  
 
 The graph above depicts the number of students who are aware that hepatitis B is 
a preventable disease. Ninety students (74.4%) reported hepatitis B is a preventable 
disease, six students (4.96%) reported hepatitis B was not a preventable disease, and 
twenty-five students (20.66%) reported they were unsure if hepatitis B was preventable.  
 
Graph E 
 Q: Do you believe that vaccines are a safe method to prevent disease(s)? 
 
 Percentage of students based on beliefs regarding vaccine use  
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 The graph above illustrates the belief that vaccines are a safe method to prevent 
disease(s).  112 students (92.56%) responded they do believe that vaccines are a safe 
method to prevent diseases, four students (3.31%) responded they did not believe 
vaccines are a safe method to disease prevention, and five students (4.13%) responded 
they were unsure if vaccines were a safe method to disease prevention.  
 
Graph F 
Q: Do you believe that vaccines are safe and beneficial to disease prevention? 
 
 
 
 
 
 
 The graph above depicts the belief that vaccines are safe and beneficial to disease 
prevention. One hundred and eleven students (91.74%) responded they believe vaccines 
are a safe and beneficial to disease prevention, four students (3.31%) responded they do 
not believe vaccines are safe and beneficial to disease prevention, and six students 
Percentage of students based on beliefs regarding vaccine safety and benefit to disease 
prevention  
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(4.96%) responded they were unsure if vaccines are safe and beneficial to disease 
prevention. 
 
Graph G 
Q: Do you believe parents should vaccinate their child/children? 
 
	
	
	
	
	 The graph above illustrates students’ belief that parents should vaccinate their 
child/children.  115 students (95.83%) reported they believe parents should vaccinate 
Student responses to beliefs regarding parental decision to 
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their children. Three students reported they do not believe parents should vaccinate their 
children, and two students preferred not to answer.  
Graph H 
Q: As a parent, would you vaccinate your child/children? 
 
	
 
  
 
The graph above illustrates whether or not a student would vaccinate his or her 
child/children. 
115 students (95.04%) responded they would vaccinate their child/children, two students 
(1.65%) reported they would not vaccinate their child/children, and four students (3.31%) 
reported that they preferred not to answer.   
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Table 1A 
Hepatitis B familiarity based on classification 
 
Q: Are you familiar with Hepatitis B? 
 
Classification No Yes 
Sample 
proportions  
[Weighted col % 
(95%CI)] 
Freshman 6.0 9.0 .4000000 (.1520774-.6479226) 
Sophomore 14.0 12.0 .5384615 (.3468372-.7300859) 
Junior 8.0 22.0 .2666667 (.1084215-.4249119) 
Senior 11.0 21.0 .3437500 (.1791851-.5083149) 
Graduate 
Student 
 (in pursuit of 
Masters or 
Ph.D.) 3.0 15.0 .1666667 
(-.00501784-
.338835117) 
 
 The two- way classification table above reports hepatitis B familiarity based on 
classification. The total sample consisted of fifteen freshmen, (12.40%), twenty-six 
sophomores (21.49%), thirty juniors (24.48%), thirty-two seniors (26.44%), and eighteen 
graduate students (14.88%).  Of the fifteen students classified as freshman, six (40%) 
reported that they were not familiar with hepatitis B and nine (60%) reported that they 
were familiar with hepatitis B. Of the twenty-six students classified as sophomores, 
fourteen (53.8%) reported that they were not familiar with hepatitis and twelve (46.2%) 
reported that they were familiar with hepatitis B.  Of the thirty students classified as 
juniors, eight (26.7%) responded they were not familiar with hepatitis B and twenty-two 
(73.3%) reported they were familiar with hepatitis B.  Of the thirty-three students 
classified as seniors, eleven (34.4%) reported they were not familiar with hepatitis B and 
twenty-one (65.6%) reported they were familiar with hepatitis B. Lastly, of the eighteen 
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students classified as graduate students, three (16.7%) responded they were unfamiliar 
with hepatitis B and fifteen (83.3%) reported they were familiar with hepatitis B.  
 
Table 1B (Data) 
* 10% significance level with a p-value =.098 
 
x-squared df p -value 
7.8303 4.0 .098 
  
 Using a five sample test for equality of proportions without continuity correction 
at a 10% significance level, the p-value of .098 illustrates that the proportion of students 
familiar with hepatitis B differs by classification. 
  
 
Table 2A 
Hepatitis B familiarity based on gender 
 
Gender No Yes 
Sample 
proportion 
[Weighted col % 
(95%CI)] 
Female 27.0 57.0 0.3214286 (-.3045798-.1141036) 
Male 15.0 21.0 0.4166667  
 
 The two-way classification table above reports hepatitis B familiarity based on 
gender using a two sample test. The total sample consisted of thirty-six males (30%) and 
eighty-four females (70.00%). Of the thirty-six male participants, fifteen (41.7%) 
reported they were not familiar with hepatitis B and twenty-one (58.3%) reported they 
were.  Of the eighty-four female participants, twenty-seven (32.1%) reported they were 
unfamiliar with hepatitis B and fifty-seven (67.9%) reported they were familiar with 
hepatitis.  
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Table 2B (Data) 
 
x-squared df p-value 
0.62960 1.0 .4275 
 
 A 2-sample test for equality of proportions with continuity correction recorded a 
p-value of .4275, which indicates that gender is not a significant factor on the influence 
of hepatitis B familiarity. 
 
Table 3A 
Hepatitis B Familiarity based on major (science vs. non-science) 
 
Major No Yes 
Sample 
Proportions 
[Weighted col 
% (95%CI)] 
Non-Science 18.0 25.0 0.4186047 
(-0.05779725 -
1.00000000) 
Science 24.0 54.0 0.3076923  
  
 The two-way classification table above reports hepatitis B familiarity based on 
majors. The total sample consisted of eighty participants (65.04%) with science or 
applied science majors and forty-three participants (34.96%) with non-science majors. Of 
the forty-three non-science majors, eighteen (41.9%) were unfamiliar of hepatitis B and 
twenty-five (58.1%) were familiar with hepatitis B. Of the eighty students with science or 
applied science majors, twenty-four (30.8%) were unfamiliar with hepatitis B and fifty-
four (69.1%) were familiar with hepatitis B.  
 
Table 3B (Data) 
 
x-squared df p-value 
1.055 1.0 .1522 
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 A two-sample test for equality of proportions with continuity correction recorded 
a p-value of .1522, which illustrates some evidence that science majors may be more 
knowledgeable of hepatitis B, but there is no significance.  
 
Table 4 
Beliefs regarding vaccine safety and benefit(s) to disease prevention based on 
classification 
 
Q: Do you believe that vaccines are safe and beneficial to disease prevention? 
 
Classification  Yes No I am not sure p-value 
Freshman 14.0 1.0 0.0 .9472 
Sophomore 25.0 1.0 0.0  
Junior 25.0 1.0 4.0  
Senior 29.0 1.0 2.0  
Graduate Student (in 
pursuit of Masters or 
Ph.D.) 18.0 0.0 0.0 
 
 
 
 The two- way classification table above reports beliefs regarding vaccine safety 
and benefit(s) to disease prevention based on classification. The total sample consisted of 
fifteen freshmen, (13.01%), twenty-six sophomores (21.14%), thirty juniors (24.39%), 
thirty-three seniors (26.83%), and eighteen graduate students (14.63%). Of the fifteen 
freshman respondents, fourteen (93.4%) believed that vaccines are safe and beneficial to 
disease prevention, 1(6.6%) did not believe vaccines are safe and beneficial to disease 
prevention, and zero (0%) were unsure of their belief.  Of the twenty-six students 
classified as sophomores, twenty-five (96.2%) believed that vaccines are safe and 
beneficial to disease prevention, one (3.8%) did not believe vaccines are safe and 
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beneficial to disease prevention, and zero (0%) were unsure of their belief. Of the thirty 
students classified as juniors, twenty-five (83.3%) believed that vaccines were safe and 
beneficial to disease prevention, one (3.3%) did not believe vaccines were safe and 
beneficial to disease prevention, and four (13.3%) were unsure of their belief. 
Of the thirty-three students classified as seniors, twenty-nine (90.6%) believed that 
vaccines are safe and beneficial to disease prevention, one (3.1%) did not believe 
vaccines were safe and beneficial to disease prevention, and two (6.3%) were unsure of 
their beliefs. Lastly, of the eighteen students classified as graduate students, eighteen 
students (100%) believed that vaccines are safe and beneficial to disease prevention, zero 
students (0.0%) did not believe vaccines are safe and beneficial to disease prevention, 
and zero students (11.1%) were unsure of their belief. 
 
 Based on the p-value (.9472) determined by the fisher’s exact test, classification is 
an important factor for beliefs on vaccine safety and benefit to disease prevention.   
 
Table 5A  
Beliefs regarding vaccine safety and benefit(s) to disease prevention based on gender 
 
Gender Yes No I am not sure 
Sample 
Proportions 
[Weighted 
col % 
(95%CI)] 
Female 75.0 4.0 5.0 
0.9493671 
(-.11959458-
.01832876) 
Male 35.0 0.0 1.0 1.00000  
  
 The- two-way classification table above reports beliefs regarding vaccine safety 
and benefit(s) to disease prevention based on gender. The total sample consisted of 36 
males (29.27%) and 86 females (69.92%).  Of the eight-four females who responded to 
this question, seventy-five (89.3%) believed vaccines are safe and beneficial to disease 
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prevent, four (4.8%) did not believe vaccines are safe and beneficial to disease 
prevention, and five (5.9%) were unsure of their beliefs.  Of the thirty-six male 
participants, sixteen (97.2%) believed vaccines are safe and beneficial to disease 
prevention, zero (0%) did not believe vaccines are safe and beneficial to disease 
prevention, and one (2.8%) were unsure of their belief. 
Beliefs regarding vaccine safety and benefit(s) to disease prevention based on gender 
 
Table 5B (Data) 
 
x-squared df p-value 
0.64553 1.0 .4217 
 
 
 Based on the p-value (.4217) determined by a two-sample test for equality of 
proportions with continuity correction, gender is not a factor for beliefs regarding vaccine 
safety and benefit(s) to disease prevention. 
 
Table 6A 
Beliefs regarding vaccine safety and benefit(s) to disease prevention based on major 
 
Major Yes No 
I am not 
sure 
Sample 
proportions 
[Weighted 
col % 
(95%CI)] 
Non-science 37.0 1.0 5.0 
0.9736842 
-0.06677037-
0.09206087 
Science 74.0 3.0 1.0 0.9610390  
 
 Of the forty-three students with non-science majors, thirty-seven (86.0%) 
believed that vaccines are safe and beneficial to disease prevention, one (14.0%) did not 
believe vaccines are safe and beneficial to disease prevention, and five (11.6%) were 
unsure of their belief.  Of the seventy-eight students with science majors seventy-four 
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(94.8%) believe that vaccines are safe and beneficial to disease prevention, three (3.8%) 
did not believe vaccines are safe and beneficial, and one (1.3%) were unsure of their 
beliefs.  
Table 6B Data 
 
x-squared df p-value 
2.7246𝑒!!" 1.0 1.0 
 
 Based on the p-value of .9788, determined by a 2-sample test for equality of 
proportions with continuity correction, majoring in science/ applied science or non-
science is not a factor in beliefs regarding vaccine safety and benefits (s) to disease 
prevention.   
Discussion: 
 Considering the 1995 ACCIP recommendations and the University of 
Mississippi’s current vaccine requirements, the final results of the study are 
difficult to explain. Potential explanations for the findings of this study are; (a) the 
distribution of vaccines generally occurs during early childhood/ infancy, so 
students may be unaware of their vaccination status (b) the presence of a deficit in 
educational efforts to increase awareness of vaccine use, hepatitis B, and other 
preventable diseases (c) the presence and strength of various social stigmas 
regarding hepatitis B infection, hepatitis B transmission, and vaccine use limits 
their discussion (d) the presence of an age gap limiting the opportunity to witness 
the effects of preventable diseases prior to the creation and wide spread 
distribution of vaccines (e) a lack of a clear incentive associated with the 
knowledge and awareness of hepatitis B and vaccine use among University of 
Mississippi students and (f) the strength of the beliefs in which an individual uses 
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to identify his/herself.  Although the population of this study was comprised of 
non-high risk college students, the results illustrate the influence of educational, 
social, and environmental factors on the knowledge and awareness of hepatitis B 
and vaccine use as a safe preventative measure- even among educated individuals.  
An influx of educated individuals that are unaware of hepatitis B and vaccine use 
as preventative measure for deadly infectious microbes poses a threat to current 
eradication of preventable infectious diseases.  Thus, it is reasonable to develop 
strategies that incorporate education of hepatitis B, hepatitis B transmission, and 
vaccine safety and use, while also working to minimize the effects of social 
scrutiny.  
Conclusion 
 As seen in other parts of the world, once an infectious disease is 
introduced to a non-vaccinated population it could spread very rapidly.” (Flag 
Wars). An increase in the number of U.S. parents and educated individual 
expressing opposition to vaccinations against Hepatitis B and other infectious 
diseases poses a significant threat of the re-introduction of infectious diseases 
among non-vaccinated populations. A lack of knowledge and awareness of 
hepatitis B infection and transmission and vaccine use among highly educated 
students indicates the need for the implementation of specific educational 
programs at the University of MS directed towards; (a) increasing knowledge and 
awareness of preventable diseases, such as hepatitis B, (b) minimizing social 
stigmas associated with these topics, and (c)  encouraging and increasing the use 
of strong educational backgrounds, specifically in science related subjects, to 
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motivate others to consider the risk side of  infectious diseases even when the 
symptoms are not visible.  
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